# EDGAR Filing Document

**Accession Number:** 0001660046
**File Stem:** 0001213900-25-107338
**Filing Date:** 2025-11
**Character Count:** 10540
**Document Hash:** 6438060ff43e122fa0f7a6af1bf427c4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-107338.hdr.sgml**: 20251107

**ACCESSION NUMBER**: 0001213900-25-107338

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 6

**CONFORMED PERIOD OF REPORT**: 20251107

**FILED AS OF DATE**: 20251107

**DATE AS OF CHANGE**: 20251106

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Immuron Ltd
- **CENTRAL INDEX KEY:** 0001660046
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** C3
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38104
- **FILM NUMBER:** 251460126

**BUSINESS ADDRESS:**
- **STREET 1:** 62 LYGON STREET
- **STREET 2:** LEVEL 3
- **CITY:** CARLTON, VICTORIA
- **STATE:** C3
- **ZIP:** 3053
- **BUSINESS PHONE:** 61 03 9824 5254

**MAIL ADDRESS:**
- **STREET 1:** 62 LYGON STREET
- **STREET 2:** LEVEL 3
- **CITY:** CARLTON, VICTORIA
- **STATE:** C3
- **ZIP:** 3053

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16 UNDER**

**THE SECURITIES EXCHANGE ACT OF 1934**

For the Month of November 2025

Commission File Number: 001-38104

**<u>IMMURON LIMITED</u>**

(Name of Registrant)

**<u>Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia</u>**

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No ☒

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

**IMMURON LIMITED**

**<u>EXPLANATORY NOTE</u>**

Immuron Limited (the "Company") published two announcements (the "Public Notices") to the Australian Securities Exchange on November 7, 2025 titled:

99.1 [Application for quotation of securities](ea026450301ex99-1_immuron.htm)

99.2 [Cleansing Notice](ea026450301ex99-2_immuron.htm)

A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

This report on Form 6-K (including the exhibit hereto) shall not be deemed to be "filed" for purposes of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

**EXHIBITS**

---

| | |
|:---|:---|
| **Exhibit** <br> **Number** | **Description** |
| 99.1 | [Application for quotation of securities](ea026450301ex99-1_immuron.htm) |
| 99.2 | [Cleansing Notice](ea026450301ex99-2_immuron.htm) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **IMMURON LIMITED** | **IMMURON LIMITED** |
| Date: November 7, 2025 | By: | /s/ Phillip Hains |
|  |  | Phillip Hains |
|  |  | Company Secretary |

---

## Exhibit 99.1

**Exhibit 99.1**

---

| | |
|:---|:---|
| ![](ex99-1_001.jpg) | Appendix 2A - Application for quotation of securities |

---

Announcement Summary

**Entity name**

**IMMURON LIMITED**

**Announcement Type**

**New announcement**

**Date of this announcement**

Friday November 07, 2025

**The +securities to be quoted are:**

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

**Total number of +securities to be quoted**

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**ASX +security code** | **Security description** | **Number of +securities to** |  |
|  |  | **be quoted** | **Issue date** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**IMC** | **ORDINARY FULLY PAID** | **8,495,080** | 07/11/2025 |

---

**Refer to next page for full details of the announcement**

Appendix 2A - Application for quotation of securities 1 / 6

---

| | |
|:---|:---|
| ![](ex99-1_001.jpg) | Appendix 2A - Application for quotation of securities |

---

Part 1 - Entity and announcement details

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1 Name of entity**

**IMMURON LIMITED**

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.2 Registered Number Type** | **Registration Number** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ACN | 063114045 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.3 ASX issuer code**

**IMC**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.4 The announcement is**

**New announcement**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.5 Date of this announcement**

7/11/2025

Appendix 2A - Application for quotation of securities 2 / 6

---

| | |
|:---|:---|
| ![](ex99-1_001.jpg) | Appendix 2A - Application for quotation of securities |

---

Part 2 - Type of Issue

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1 The +securities to be quoted are:

**+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B**

**Previous Appendix 3B details:** 

---

| | | |
|:---|:---|:---|
| **Announcement Date and Time** | **Announcement Title** | **Selected Appendix 3B to submit quotation request** |
| 06-Nov-2025 11:06 | New - Proposed issue of securities - IMC | A placement or other type of issue |

---

**2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?**

**No**

Appendix 2A - Application for quotation of securities 3 / 6

---

| | |
|:---|:---|
| ![](ex99-1_001.jpg) | Appendix 2A - Application for quotation of securities |

---

Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B <br>  

Placement Details

**ASX +security code and description**

IMC : ORDINARY FULLY PAID

**Issue date**

7/11/2025

Distribution Schedule

**Provide a distribution schedule for the new +securities according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities held by the recipients in each category.**

---

| | | |
|:---|:---|:---|
| **Number of +securities held** | **Number of holders** | **Total percentage of +securities held**<br>For example, to enter a value of 50% |
|  |  | please input as 50.00 |
| 1 - 1000 |  | % |
| 1001 - 5000 |  | % |
| 5001 - 10000 |  | % |
| 10001 - 100000 |  | % |
| 100,001 and over |  | % |

---

Appendix 2A - Application for quotation of securities 4 / 6

---

| | |
|:---|:---|
| ![](ex99-1_001.jpg) | Appendix 2A - Application for quotation of securities |

---

Issue details

**Number of +securities to be quoted**

8,495,080

**Are the +securities being issued for a cash consideration?**

Yes

---

| | |
|:---|:---|
| **In what currency is the cash consideration being paid?** | **What is the issue price per +security?** |
| AUD - Australian Dollar | AUD 0.07560000 |

---

**Any other information the entity wishes to provide about the +securities to be quoted**

The shares were purchased by US investors from the US At-The-Market (ATM) facility (managed by H.c. Wainwright & Co.) This is a low fee, no discount facility.<br>

Appendix 2A - Application for quotation of securities 5 / 6

---

| | |
|:---|:---|
| ![](ex99-1_001.jpg) | Appendix 2A - Application for quotation of securities |

---

Part 4 - Issued capital following quotation <br>  

**Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:**

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)**

---

| | |
|:---|:---|
| **ASX +security code and description** | **Total number of <br> +securities on issue** |
| IMC : ORDINARY FULLY PAID | 277848893 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)**

---

| | |
|:---|:---|
| **ASX +security code and description** | **Total number of<br> +securities on issue** |
| IMCAE : PERFORMANCE RIGHTS | 7610315 |
| IMCAI : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES | 5430000 |

---

Appendix 2A - Application for quotation of securities 6 / 6

## Exhibit 99.2

**Exhibit 99.2**

![](ex99-2_001.jpg)

**Notice Under Section 708A(5) of the Corporations Act**

Melbourne, Australia, November 7, 2025

This notice is given by Immuron Limited (ASX: IMC; NASDAQ: IMRN) under section 708A(5)(e) of the Corporations Act 2001 (the 'Corporations Act').

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Type** | &nbsp;&nbsp;Shares |
| &nbsp;&nbsp;**Class** | &nbsp;&nbsp;Ordinary |
| &nbsp;&nbsp;**ASX code** | &nbsp;&nbsp;IMC |
| &nbsp;&nbsp;**Date of Issue** | &nbsp;&nbsp;7 November 2025 |
| &nbsp;&nbsp;**Number Issued** | &nbsp;&nbsp;8495080 |

---

The Company gives notice under section 708A(5)(e) of the Corporations that:

1. the Company issued the Shares without disclosure under Part 6D.2 of the Corporations Act;

2. as at the date of this notice the Company has complied with:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and

(ii) sections 674 and 674A of the Corporations Act; and

3. as at the date of this notice, there is no information to be disclosed which is 'excluded information'
(as defined in sections 708A(7) and 708A(8) of the Corporations Act) which is required to be disclosed by the Company.

Phillip Hains

Company Secretary

![](ex99-2_002.jpg)